Gene Therapy for Cardiovascular and Cerebrovascular Disease: Mechanisms, Translational Barriers, and the Road Ahead

Zixu Liu1, Ruiqi Liu1, Ying Ying2

  • 1Queen Mary College, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.

Biomedicines
|May 27, 2026
PubMed

Insights

Gene therapy offers new hope for cardiovascular and cerebrovascular diseases like arrhythmias, atherosclerosis, and stroke. These advanced treatments target root causes, potentially transforming patient outcomes beyond conventional care.

Area of Science:

  • Cardiovascular and cerebrovascular research
  • Genetic medicine
  • Translational science

Background:

  • Cardiovascular and cerebrovascular diseases are leading causes of death and disability worldwide.
  • Conventional therapies leave significant residual risk, necessitating novel interventions.
  • Gene-based approaches offer potential to address underlying molecular pathology.

Purpose of the Study:

  • To review current gene therapy strategies for cardiovascular and cerebrovascular diseases.
  • To synthesize mechanistic understanding, translational obstacles, and future directions.
  • To evaluate gene therapy's potential to complement standard care.

Main Methods:

  • Review of gene-based interventions including KCNQ1/KCNH2 suppression, SCN5A base editing, PKP2/TMEM43 restoration for arrhythmias.
  • Analysis of RNA-based agents (inclisiran) and in vivo editing (VERVE-101) for atherosclerosis.
  • Examination of cGAS-STING silencing, AAV-NeuroD1 reprogramming, and neurotrophic factor delivery for ischemic stroke.

Main Results:

  • Gene therapies show promise in stabilizing electrophysiology, reducing lipids, and attenuating vascular inflammation.
  • Specific strategies like AAV-NeuroD1 and neurotrophic factors extend therapeutic windows post-stroke.
  • These approaches address fundamental molecular causes, offering a new therapeutic paradigm.

Conclusions:

  • Gene therapy presents a meaningful complement to existing treatments for cardiovascular and cerebrovascular diseases.
  • Despite delivery and safety challenges, gene therapy is poised to significantly impact disease prevention and treatment.
  • Addressing root molecular pathology offers a transformative potential for managing these conditions.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...